POS0694 What treatment gives the best clinical response after cessation of JAKi therapy in patients with RA? data of the TARDIS-RA registry, a nationwide belgian biologic registry

BACKGROUND JAKi represent a new important class in Rheumatoid Arthritis (RA) treatment options. It is unknown which specific bDMARD or mode of action should be selected after stopping a JAKi. OBJECTIVES To study if clinical response differs between advanced therapies that are initiated after stopping a JAKi. METHODS Patients were included from the electronic platform “Tool for Administrative Reimbursement Drug Information Sharing†(TARDIS). Data from all Belgian RA patients on biologic and targeted therapy are collected here for drug reimbursement. Patients were selected for this analysis i... Mehr ...